Literature DB >> 20648589

Outcome in adult patients with head and neck sarcomas--a 10-year analysis.

Thomas Mücke1, David A Mitchell, Andrea Tannapfel, Frank Hölzle, Marco R Kesting, Klaus-Dietrich Wolff, Andreas Kolk, Anastasios Kanatas.   

Abstract

BACKGROUND AND
OBJECTIVE: Sarcomas of the head and neck in adults are malignant tumors with many histological subtypes and sites of origin. The purpose of this study was to analyze the outcome of adult patients suffering from head and neck sarcomas and to identify any clinical and histological predictors of outcome.
MATERIALS AND METHODS: The medical records of 74 patients treated during 1999-2008 were reviewed. All patients suffered from primary head and neck sarcomas.
RESULTS: The mean survival of patients was 44.49 +/- 32.25 months. The 2- and 5-year overall survival rates were 83.78% and 60.81%. The nodal status (P = 0.032), tumor size (P < 0.0001), tumor location (P = 0.03), histological type (P = 0.002), the involvement of bone (P = 0.032), and age (P < 0.0001) were significant parameters influencing survival.
CONCLUSION: This study demonstrated a better than expected crude overall survival and a higher rate of recovery of involved regional lymph nodes with evidence of poorer outcome when cervical metastases are evident. It is suggested that this may reflect the impact of specialist head and neck surgical techniques (applicable to all head and neck malignancy) as well as the recognized need for specialization in pathology and nonsurgical oncology in the care of these patients. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20648589     DOI: 10.1002/jso.21595

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Head and neck sarcomas: treatment outcomes in a tertiary referral center in Argentina.

Authors:  Alejandro Yanzon; Natalia Lucia Gomez; Pedro Picco; Luis Boccalatte; Federico Cayol; Juan Larrañaga; Marcelo Figari
Journal:  Oral Maxillofac Surg       Date:  2021-02-15

2.  Anterior Skull Base Sarcomas: Report of Characteristics and Outcomes at a Tertiary Care Cancer Center.

Authors:  Sallie Long; Panagiotis Asimakopoulos; Marlena McGill; Marc A Cohen; Snehal G Patel; Jatin P Shah; Ian Ganly
Journal:  J Neurol Surg B Skull Base       Date:  2021-01-21

Review 3.  Lipomatous tumours of the head and neck: a spectrum of biological behaviour.

Authors:  Eelco de Bree; Alexander Karatzanis; Jennifer L Hunt; Primož Strojan; Alessandra Rinaldo; Robert P Takes; Alfio Ferlito; Remco de Bree
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-07       Impact factor: 2.503

4.  Effect of neoadjuvant treatment in the management of osteosarcomas of the head and neck.

Authors:  Thomas Mücke; David A Mitchell; Andrea Tannapfel; Klaus-Dietrich Wolff; Denys John Loeffelbein; Anastasios Kanatas
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-26       Impact factor: 4.553

5.  Pretreatment tumor sampling and prognostic factors in patients with soft-tissue sarcoma of the head and neck.

Authors:  Johan H Roos; Antti A Mäkitie; Jussi Tarkkanen; Taru T Ilmarinen
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-11-12       Impact factor: 3.236

6.  Head and Neck Soft Tissue Sarcomas Treated with Radiation Therapy.

Authors:  Lucas K Vitzthum; Lindsay C Brown; Jessica W Rooney; Robert L Foote
Journal:  Rare Tumors       Date:  2016-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.